T-group (topology)
4177.2.1 Inhibitor of kappaB kinase beta dimerization domain
Ligands and drugs
129
Member domains
2
with ligand contacts (≤ 4 Å)
1.6% of members
15
with DrugDomain annotations
11.6% of members
4
with a DrugBank compound
3.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4177.2.1 belongs to X-group 4177 BAR/IMD domain-like, which has 13 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB12010 | — | Fostamatinib | 3 |
| DB00244 | — | — | 2 |
| DB06151 | — | Acetylcysteine | 2 |
| DB00233 | — | Aminosalicylic acid | 1 |
| DB00945 | — | Acetylsalicylic acid | 1 |
| DB00995 | — | — | 1 |
| DB01169 | — | — | 1 |
| DB06521 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 5TL | 2-azanyl-5-phenyl-3-(4-sulfamoylphenyl)benzamide | 1 |
| HGmetal | MERCURY (II) ION | 1 |